An economic analysis of robotically assisted hysterectomy.

Area of Science:

• Gynecologic Oncology
• Health Economics
• Surgical Innovation

Background:

• Robot-assisted hysterectomy is increasingly adopted for gynecologic conditions.
• Understanding cost drivers is crucial for healthcare resource allocation.
• Variations in hospital accounting and analytic methods may influence cost perceptions.

Purpose of the Study:

• To analyze the impact of procedure volume, hospital accounting, and analytic methods on the cost of robot-assisted hysterectomy.
• To compare costs between robot-assisted and laparoscopic hysterectomy for benign and malignant gynecologic conditions.

Main Methods:

• Econometric analysis of a national sample of hysterectomies (2006-2012).
• Classification of surgeon and hospital volume based on prior procedures.
• Multivariable quantile regression to model total, fixed, and variable costs.

Main Results:

• Robot-assisted hysterectomy was more expensive than laparoscopic hysterectomy for both benign ($8,152 vs. $6,535) and endometrial cancer ($9,691 vs. $8,237) indications.
• Cost difference decreased with increasing surgeon and hospital volume.
• For endometrial cancer, the cost gap reduced from $1,761 (fewer than 5 cases) to $688 (over 50 cases) with higher surgeon volume.

Conclusions:

• Increased procedure volume significantly reduces the cost of robotic gynecologic surgery.
• Despite volume-related cost reductions, robot-assisted hysterectomy remains substantially more expensive than laparoscopic hysterectomy.